HARTMAN L

Last name: HARTMAN L

2022 (v1)

Publication

Metadata-only

Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.

Hartman L da Silva JAP Buttgereit F

No description

Uploaded on: January 31, 2024
2022 (v1)

Publication

Metadata-only

Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Hartman L El Alili M Cutolo M

No description

Uploaded on: February 14, 2024
2018 (v1)

Publication

Metadata-only

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Hartman L Rasch LA Klausch T

Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints affecting 1% of the world population. It has major impact on patients through disability and associated comorbidities. Current treatment strategies have considerably improved the prognosis, but recent innovations (especially biologic drugs and the new class of so-called...

Uploaded on: April 14, 2023
2023 (v1)

Publication

Metadata-only

Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

Almayalım AAH Boers M Hartman L

Objective: The randomised placebo-controlled GLORIA (Glucocorticoid LOw-dose in RheumatoId Arthritis) trial evaluated the benefits and harms of prednisolone 5 mg/day added to standard care for 2 years in patients aged 65+ years with rheumatoid arthritis (RA). Here, we studied disease activity, flares and possible adrenal insufficiency after...

Uploaded on: February 13, 2024
2022 (v1)

Publication

Metadata-only

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.

Boers M Hartman L Opris-Belinski D

No description

Uploaded on: February 14, 2024

HARTMAN L

Recent uploads